Background and Purpose-Cerebral cavernous malformation (CCM) is characterized by multiple lumen vascular malformations in the central nervous system that can cause neurological symptoms and brain hemorrhages. About 20% of CCM patients have an inherited form of the disease with ubiquitous loss-of-function mutation in any one of 3 genes CCM1, CCM2, and CCM3. The rest of patients develop sporadic vascular lesions histologically similar to those of the inherited form and likely mediated by a biallelic acquired mutation of CCM genes in the brain vasculature. However, the molecular phenotypic features of endothelial cells in CCM lesions in sporadic patients are still poorly described. This information is crucial for a targeted therapy. Methods-We used immunofluorescence microscopy and immunohistochemistry to analyze the expression of endothelial-to-mesenchymal transition markers in the cavernoma of sporadic CCM patients in parallel with human familial cavernoma as a reference control. Results-We report here that endothelial cells, a cell type critically involved in CCM development, undergo endothelial-to-mesenchymal transition in the lesions of sporadic patients. This switch in endothelial phenotype has been described only in genetic CCM patients and in murine models of the disease. In addition, TGF-β/p-Smad-and β-catenin-dependent signaling pathways seem activated in sporadic cavernomas as in familial ones. Conclusions-Our findings support the use of common therapeutic strategies for both sporadic and genetic CCM malformations.

Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition / L. Bravi, M. Malinverno, F. Pisati, N. Rudini, R. Cuttano, R. Pallini, M. Martini, L.M. Larocca, M. Locatelli, V. Levi, G.A. Bertani, E. Dejana, M.G. Lampugnani. - In: STROKE. - ISSN 0039-2499. - 47:3(2016 Mar), pp. 886-890.

Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition

L. Bravi
Primo
;
M. Malinverno
Secondo
;
F. Pisati;N. Rudini;R. Cuttano;M. Locatelli;V. Levi;G.A. Bertani;E. Dejana
Penultimo
;
2016-03

Abstract

Background and Purpose-Cerebral cavernous malformation (CCM) is characterized by multiple lumen vascular malformations in the central nervous system that can cause neurological symptoms and brain hemorrhages. About 20% of CCM patients have an inherited form of the disease with ubiquitous loss-of-function mutation in any one of 3 genes CCM1, CCM2, and CCM3. The rest of patients develop sporadic vascular lesions histologically similar to those of the inherited form and likely mediated by a biallelic acquired mutation of CCM genes in the brain vasculature. However, the molecular phenotypic features of endothelial cells in CCM lesions in sporadic patients are still poorly described. This information is crucial for a targeted therapy. Methods-We used immunofluorescence microscopy and immunohistochemistry to analyze the expression of endothelial-to-mesenchymal transition markers in the cavernoma of sporadic CCM patients in parallel with human familial cavernoma as a reference control. Results-We report here that endothelial cells, a cell type critically involved in CCM development, undergo endothelial-to-mesenchymal transition in the lesions of sporadic patients. This switch in endothelial phenotype has been described only in genetic CCM patients and in murine models of the disease. In addition, TGF-β/p-Smad-and β-catenin-dependent signaling pathways seem activated in sporadic cavernomas as in familial ones. Conclusions-Our findings support the use of common therapeutic strategies for both sporadic and genetic CCM malformations.
CCM; EndMT; endothelium; immunohistochemistry; intracranial hemorrhage; adolescent; adult; aged; central nervous system neoplasms; child; endothelium, vascular; female; hemangioma, cavernous, central nervous system; humans; male; middle aged; young adult; epithelial-mesenchymal transition; cardiology and cardiovascular medicine; neurology (clinical); advanced and specialized nursing
Settore MED/04 - Patologia Generale
Article (author)
File in questo prodotto:
File Dimensione Formato  
2016_Stroke_Bravi.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 3.8 MB
Formato Adobe PDF
3.8 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/425129
Citazioni
  • ???jsp.display-item.citation.pmc??? 22
  • Scopus 41
  • ???jsp.display-item.citation.isi??? 39
social impact